# The Metabolomics of Anaphylaxis

> **NCT01666275** · — · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Patients With AERD Undergoing Aspirin Desensitization

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01666275
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2017-12
- **Final completion:** 2018-08-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We are closing the study because of lack of enrollment.
- **Last updated:** 2019-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666275, "The Metabolomics of Anaphylaxis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01666275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*